BR112012002639A2 - métodos e composições para melhorar a saude gastrintestinal - Google Patents

métodos e composições para melhorar a saude gastrintestinal

Info

Publication number
BR112012002639A2
BR112012002639A2 BR112012002639A BR112012002639A BR112012002639A2 BR 112012002639 A2 BR112012002639 A2 BR 112012002639A2 BR 112012002639 A BR112012002639 A BR 112012002639A BR 112012002639 A BR112012002639 A BR 112012002639A BR 112012002639 A2 BR112012002639 A2 BR 112012002639A2
Authority
BR
Brazil
Prior art keywords
compositions
health
methods
improving
gastrointestinal health
Prior art date
Application number
BR112012002639A
Other languages
English (en)
Other versions
BR112012002639B1 (pt
Inventor
Carolyn Jean Cupp
Dorothy Pauline Laflamme
Hui Xu
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112012002639A2 publication Critical patent/BR112012002639A2/pt
Publication of BR112012002639B1 publication Critical patent/BR112012002639B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/163—Sugars; Polysaccharides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

métodos e composições para melhorar saude gastrintestinal. métodos para a manutenção ou melhoria da saúde gastrintestinal de animais suscetíveis ou que esteja sofrendo de má saúde intestinal através da administração ao animal de uma quantidade para a manutenção, ou a melhoria da saúde de composição de alimento que compreende a partir de cerca de 1 até cerca de 20% de carboidratos, a partir de cerca de 3 até cerca de 10% de fibra dietética total, em que o total de fibra dietética contem a partir de cerca de 10 até cerca de 40% de fibra solúvel e a partir de cerca de 90 até cerca de 60% de fibra insolúvel, e a partir de cerca de 0,1 até cerca de 10% de ácidos graxos de omega 3, em que a composição tem um coeficiente de digestibilidade de pelo menos 80. em geral, as composições são administrativas ao animal para previnir ou tratar a diarréia ou melhorar a qualidade das fezes. alem disso, as composições podem ser administradas em conjunto com um ou mais probióticos, prébioticos, fármacos anti gastrite, fármacos anti enterite, fármacos anti diarréia, ]exopolissacarídeos microbianos, ou combinações dos mesmos para a manutenção ou a melhoria da saúde gastrintestinal.
BR112012002639-9A 2009-08-05 2010-08-04 composições para manter ou melhorar a saúde gastrintestinal de um animal, e uso BR112012002639B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27350609P 2009-08-05 2009-08-05
US61/273,506 2009-08-05
PCT/US2010/002179 WO2011016866A1 (en) 2009-08-05 2010-08-04 Methods and compositions for improving gastrointestinal health

Publications (2)

Publication Number Publication Date
BR112012002639A2 true BR112012002639A2 (pt) 2016-03-22
BR112012002639B1 BR112012002639B1 (pt) 2020-12-08

Family

ID=43535277

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012002639-9A BR112012002639B1 (pt) 2009-08-05 2010-08-04 composições para manter ou melhorar a saúde gastrintestinal de um animal, e uso

Country Status (13)

Country Link
US (1) US8691792B2 (pt)
EP (1) EP2461799B1 (pt)
JP (1) JP2013501044A (pt)
CN (1) CN102573798B (pt)
AU (1) AU2010281646C1 (pt)
BR (1) BR112012002639B1 (pt)
CA (1) CA2769689C (pt)
ES (1) ES2588679T3 (pt)
IN (1) IN2012DN00760A (pt)
MX (1) MX2012001460A (pt)
RU (1) RU2561679C2 (pt)
WO (1) WO2011016866A1 (pt)
ZA (1) ZA201201600B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US11540066B2 (en) 2011-12-23 2022-12-27 Shenzhen Shokz Co., Ltd. Bone conduction speaker and compound vibration device thereof
US11528562B2 (en) 2011-12-23 2022-12-13 Shenzhen Shokz Co., Ltd. Bone conduction speaker and compound vibration device thereof
US11641551B2 (en) 2011-12-23 2023-05-02 Shenzhen Shokz Co., Ltd. Bone conduction speaker and compound vibration device thereof
US11716575B2 (en) 2011-12-23 2023-08-01 Shenzhen Shokz Co., Ltd. Bone conduction speaker and compound vibration device thereof
US11641552B2 (en) 2011-12-23 2023-05-02 Shenzhen Shokz Co., Ltd. Bone conduction speaker and compound vibration device thereof
US11463814B2 (en) 2011-12-23 2022-10-04 Shenzhen Shokz Co., Ltd. Bone conduction speaker and compound vibration device thereof
US9036888B2 (en) * 2012-04-30 2015-05-19 General Electric Company Systems and methods for performing quality review scoring of biomarkers and image analysis methods for biological tissue
JP2015520613A (ja) * 2012-05-21 2015-07-23 ザ・アイムス・カンパニーＴｈｅ Ｉａｍｓ Ｃｏｍｐａｎｙ 押出ペットフード組成物
JP6290080B2 (ja) * 2012-07-31 2018-03-07 株式会社カネカ 新規乳酸菌
JP6334845B2 (ja) * 2013-03-29 2018-05-30 ユニ・チャーム株式会社 肥満リスク低減用ペットフード及びペットの肥満リスク低減方法
MY186844A (en) 2014-07-09 2021-08-25 Cadena Bio Inc Oligosaccharide compositions and methods for producing thereof
SI3071235T1 (en) 2015-01-26 2018-04-30 Kaleido Biosciences, Inc. THERAPEUTIC GLITTERS AND THE RELATED METHOD
ES2938746T3 (es) 2015-01-26 2023-04-14 Dsm Nutritional Products Llc Composiciones de oligosacáridos para el uso como alimento para animales y sus métodos para producirlas
EP3256004A1 (en) 2015-02-13 2017-12-20 Mars, Incorporated Pet food feeding system
US20180147221A1 (en) 2015-04-23 2018-05-31 Kaleido Biosciences, Inc. Glycan therapeutic compositions and related methods thereof
MX2017013715A (es) 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
GB201522304D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product for reducing muscle breakdown
US20190014796A1 (en) * 2015-12-30 2019-01-17 Hill's Pet Nutrition, Inc. Pet Food Compositions
WO2017219106A1 (pt) * 2016-06-24 2017-12-28 Yessinergy Holding S/A Composição imunomoduladora e promotora de crescimento e de controle da população de bactérias indesejáveis da microbiota intestinal e seu uso
CN108245531B (zh) * 2016-12-29 2023-01-24 鲁南制药集团股份有限公司 一种改善胃肠道功能、防治便秘的组合物
WO2018204497A1 (en) * 2017-05-03 2018-11-08 Mars, Incorporated Pet food and method of forming thereof
WO2019090182A2 (en) 2017-11-03 2019-05-09 Kaleido Biosciences, Inc. Glycan preparations and methods of use for hyperammonemia
RU2020127230A (ru) * 2018-01-23 2022-02-14 Сосьете Де Продюи Нестле С.А. Технологический способ производства сухого жира с волокном
MX2021004361A (es) * 2018-10-18 2021-05-28 Hills Pet Nutrition Inc Composiciones alimenticias para mascotas.
US20220248716A1 (en) * 2019-07-09 2022-08-11 Hill's Pet Nutrition, Inc. Pet Food Compositions
WO2023229973A1 (en) * 2022-05-23 2023-11-30 Hill's Pet Nutrition, Inc. Pet food compositions
US20230404951A1 (en) * 2022-06-15 2023-12-21 Hill's Pet Nutrition, Inc. Pet Food Compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69909298T2 (de) * 1998-09-02 2004-05-27 Heska Corp., Fort Collins Verfahren zur herstellung einer zusammensetzung zum schutz eines fleischfressenden haustieres gegen krankheiten des abnormalen kohlenhydrat-metabolismus
GB2414916A (en) * 2002-12-23 2005-12-14 Mars Uk Ltd Food for gastrointestinal health
US20050118234A1 (en) * 2003-12-01 2005-06-02 The Iams Company Methods and kits related to administration of a fructooligosaccharide
US7754677B2 (en) * 2003-12-05 2010-07-13 Hill's Pet Nutrition, Inc. Composition and method for reducing diarrhea in a mammal
EP1811867A2 (en) * 2004-11-12 2007-08-01 N.V. Nutricia Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
US20070280964A1 (en) * 2005-10-06 2007-12-06 Ruth Knorr Compositions and methods useful for modulating immunity, enhancing vaccine efficacy, decreasing morbidity associated with chronic FHV-1 infections, and preventing or treating conjunctivitis

Also Published As

Publication number Publication date
MX2012001460A (es) 2012-06-01
RU2012108127A (ru) 2013-09-10
AU2010281646C1 (en) 2016-12-15
CN102573798A (zh) 2012-07-11
AU2010281646A1 (en) 2012-02-23
US20110034411A1 (en) 2011-02-10
EP2461799A4 (en) 2013-03-20
CN102573798B (zh) 2014-12-10
ES2588679T3 (es) 2016-11-04
EP2461799B1 (en) 2016-07-13
EP2461799A1 (en) 2012-06-13
BR112012002639B1 (pt) 2020-12-08
ZA201201600B (en) 2013-08-28
US8691792B2 (en) 2014-04-08
CA2769689C (en) 2018-11-27
JP2013501044A (ja) 2013-01-10
AU2010281646B2 (en) 2016-09-08
CA2769689A1 (en) 2011-02-10
IN2012DN00760A (pt) 2015-05-22
WO2011016866A1 (en) 2011-02-10
RU2561679C2 (ru) 2015-08-27

Similar Documents

Publication Publication Date Title
BR112012002639A2 (pt) métodos e composições para melhorar a saude gastrintestinal
Zheng et al. Current trends in marine algae polysaccharides: The digestive tract, microbial catabolism, and prebiotic potential
Walsh et al. Multi-functional roles of chitosan as a potential protective agent against obesity
Samanta et al. Prebiotic inulin: Useful dietary adjuncts to manipulate the livestock gut microflora
Chen et al. Effects of natural dietary supplementation with Macleaya cordata extract containing sanguinarine on growth performance and gut health of early‐weaned piglets
A. Parnell et al. Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome
Liu et al. Dietary Saccharomyces cerevisiae cell wall extract supplementation alleviates oxidative stress and modulates serum amino acids profiles in weaned piglets
Pinna et al. The utilisation of prebiotics and synbiotics in dogs
ES2571856T3 (es) Uso de composiciones nutricionales para prevenir la adiposidad visceral
Sweeney et al. Evaluation of seaweed-derived polysaccharides on indices of gastrointestinal fermentation and selected populations of microbiota in newly weaned pigs challenged with Salmonella Typhimurium
JP2010540444A (ja) 遺伝子産物の濃縮または活性を調節するためのレスベラトロールを含む組成物
Fu et al. Properties of hydrolyzed guar gum fermented in vitro with pig fecal inocula and its favorable impacts on microbiota
Kim et al. Effects of the polysaccharide from the sporophyll of brown alga Undaria pinnatifida on serum lipid profile and fat tissue accumulation in rats fed a high‐fat diet
BR112020012615A2 (pt) uso de uma fração de lignina como ingrediente de suplemento alimentar humano e animal
Tindall et al. Tree nut consumption and adipose tissue mass: mechanisms of action
Wolf Gut microbiota: a factor in energy regulation
Varley et al. Effect of dietary mineral level and inulin inclusion on phosphorus, calcium and nitrogen utilisation, intestinal microflora and bone development
El-Ratel et al. Productive performance, carcass traits, lipid profile, antioxidants and immunity of growing rabbits treated with gum Arabic under Egyptian summer condition
Li et al. Effects of alfalfa levels on carcass traits, meat quality, fatty acid composition, amino acid profile, and gut microflora composition of Heigai pigs
Li et al. The interaction between dietary marine components and intestinal flora
Wang et al. Supplementation with yeast culture improves the integrity of intestinal tight junction proteins via NOD1/NF‐κB P65 pathway in weaned piglets and H2O2-challenged IPEC-J2 cells
Xia et al. Combined analysis of the effects of exposure to blue light in ducks reveals a reduction in cholesterol accumulation through changes in methionine metabolism and the intestinal microbiota
Montiel et al. Inulin as a growth promoter in diets for rabbits
Okazaki et al. Protective effect of dietary lily bulb on dextran sulfate sodium-induced colitis in rats fed a high-fat diet
Afrose et al. Hypocholesterolemic effect of karaya saponin in Japanese laying quails (Coturnix coturnix japonica)

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/12/2020, OBSERVADAS AS CONDICOES LEGAIS.